Paper62817
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley K and 1 other. J Exp Med, 1976. Cited by 579 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modulation of the alternative complement pathways by beta 1 H globulin. Papers, record 62817. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62817
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Beta-Globulins | Major topic |
| Complement C3 | Major topic |
| Complement System Proteins | Major topic |
| Humans | |
| In Vitro Techniques | |
| Properdin |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,168,662 | A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component. | J Immunol | 1967 | https://conductscience.org/library/papers/4168662 | PubMed |
| 2 | 4,441,129 | Complement metabolism in the seronegative arthritides. | Ann Rheum Dis | 1974 | https://conductscience.org/library/papers/4441129 | PubMed |
| 3 | 4,622,188 | C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. | J Immunol | 1972 | https://conductscience.org/library/papers/4622188 | PubMed |
| 4 | 4,734,384 | Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). | J Immunol | 1973 | https://conductscience.org/library/papers/4734384 | PubMed |
| 5 | 47,888 | Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum. | J Exp Med | 1975 | https://conductscience.org/library/papers/47888 | PubMed |
| 6 | 4,972,183 | The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis. | J Immunol | 1968 | https://conductscience.org/library/papers/4972183 | PubMed |
| 7 | 4,999,095 | C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. | J Immunol | 1971 | https://conductscience.org/library/papers/4999095 | PubMed |
| 8 | 5,309,564 | A new complement inhibitor in guinea pig serum. | Jpn J Exp Med | 1969 | https://conductscience.org/library/papers/5309564 | PubMed |
| 9 | 5,661,952 | Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. | Exp Cell Res | 1968 | https://conductscience.org/library/papers/5661952 | PubMed |
| 10 | 5,806,584 | The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. | J Biol Chem | 1969 | https://conductscience.org/library/papers/5806584 | PubMed |
| 11 | 5,960,883 | Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. | Immunochemistry | 1966 | https://conductscience.org/library/papers/5960883 | PubMed |
| 12 | 6,054,730 | Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes. | Immunology | 1967 | https://conductscience.org/library/papers/6054730 | PubMed |
| 13 | 815,169 | Cleavage products of C4b produced by enzymes in human serum. | Immunochemistry | 1975 | https://conductscience.org/library/papers/815169 | PubMed |
| 14 | 819,459 | C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. | J Clin Invest | 1976 | https://conductscience.org/library/papers/819459 | PubMed |
| 15 | 948,757 | Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. | Science | 1976 | https://conductscience.org/library/papers/948757 | PubMed |
| 16 | 4,190,693 | Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide. | Biochemistry | 1970 | https://conductscience.org/library/papers/4190693 | PubMed |
| 17 | 4,211,020 | Properdin factor D. II. Activation to D by properdin. | J Exp Med | 1974 | https://conductscience.org/library/papers/4211020 | PubMed |
| 18 | 4,100,767 | The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens. | Immunochemistry | 1971 | https://conductscience.org/library/papers/4100767 | PubMed |
| 20 | 14,316,946 | ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. | J Exp Med | 1965 | https://conductscience.org/library/papers/14316946 | PubMed |
| 21 | 13,663,230 | An improved technique of agar-gel electrophoresis on microscope slides. | Clin Chim Acta | 1959 | https://conductscience.org/library/papers/13663230 | PubMed |
Cited by224
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 579 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,710,025 | Differential expression of complement Properdin and Factor H in the placentae and umbilical cords of mothers with Preeclampsia, Gestational Diabetes Mellitus and Recurrent Pregnancy Loss. | Front Immunol | 2025 | https://conductscience.org/library/papers/41710025 | PubMed |
| 40,892,880 | Identification of a Kingella kingae factor H binding protein that is the major determinant of serum resistance. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40892880 | PubMed |
| 39,753,135 | Non-canonical roles of CFH in retinal pigment epithelial cells revealed by dysfunctional rare CFH variants. | Stem Cell Reports | 2025 | https://conductscience.org/library/papers/39753135 | PubMed |
| 38,933,264 | Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots. | Front Immunol | 2024 | https://conductscience.org/library/papers/38933264 | PubMed |
| 38,566,098 | Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage. | J Transl Med | 2024 | https://conductscience.org/library/papers/38566098 | PubMed |
| 38,464,530 | Protective role of complement factor H against the development of preeclampsia. | Front Immunol | 2024 | https://conductscience.org/library/papers/38464530 | PubMed |
| 38,361,922 | Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement. | Front Immunol | 2024 | https://conductscience.org/library/papers/38361922 | PubMed |
| 36,382,387 | The Factor H protein family: The switchers of the complement alternative pathway. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36382387 | PubMed |
| 36,152,807 | Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles. | J Control Release | 2022 | https://conductscience.org/library/papers/36152807 | PubMed |
| 34,956,184 | Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice. | Front Immunol | 2021 | https://conductscience.org/library/papers/34956184 | PubMed |
| 34,945,133 | The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. | J Clin Med | 2021 | https://conductscience.org/library/papers/34945133 | PubMed |
| 34,661,896 | Innate Immune Pattern Recognition Receptors of Mycobacterium tuberculosis: Nature and Consequences for Pathogenesis of Tuberculosis. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34661896 | PubMed |
| 34,660,335 | Interactions Between Pathogenic Burkholderia and the Complement System: A Review of Potential Immune Evasion Mechanisms. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34660335 | PubMed |
| 33,995,361 | Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. | Front Immunol | 2021 | https://conductscience.org/library/papers/33995361 | PubMed |
| 33,868,311 | A Family Affair: Addressing the Challenges of Factor H and the Related Proteins. | Front Immunol | 2021 | https://conductscience.org/library/papers/33868311 | PubMed |
| 33,717,083 | Hijacking Factor H for Complement Immune Evasion. | Front Immunol | 2021 | https://conductscience.org/library/papers/33717083 | PubMed |
| 32,062,771 | Mathematical Modelling of Alternative Pathway of Complement System. | Bull Math Biol | 2020 | https://conductscience.org/library/papers/32062771 | PubMed |
| 30,766,876 | Further Insights Into the Interaction of Human and Animal Complement Regulator Factor H With Viable Lyme Disease Spirochetes. | Front Vet Sci | 2018 | https://conductscience.org/library/papers/30766876 | PubMed |
| 30,692,664 | C3 glomerulopathy - understanding a rare complement-driven renal disease. | Nat Rev Nephrol | 2019 | https://conductscience.org/library/papers/30692664 | PubMed |
| 30,260,060 | Ail provides multiple mechanisms of serum resistance to Yersinia pestis. | Mol Microbiol | 2019 | https://conductscience.org/library/papers/30260060 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CFH | 3,075 | PubTator's text mining | https://conductscience.org/library/genes/3075 | NCBI Gene |
| CFI | 3,426 | PubTator's text mining | https://conductscience.org/library/genes/3426 | NCBI Gene |
| ERVK-3 | 100,862,689 | PubTator's text mining | https://conductscience.org/library/genes/100862689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62817
GET https://conductscience.org/api/papers/v1/62817/references?page=2